News | November 18, 2024
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
March 10, 2021
Dr. Ryan Sullivan provided trial testimony on behalf of VLSI Technology in patent litigation involving Intel’s microprocessors. Based upon the testimony of Dr. Sullivan, the jury awarded damages of $2.175 billion.
Secretariat worked with Irell & Manella on behalf of VLSI Technology in patent litigation involving two microprocessor patents. VLSI claimed that nearly one billion Intel computer processors infringe its patents. The technologies at issue provide power savings and performance improvements in microprocessors.
During its work, Secretariat conducted economic analysis and provided trial testimony to determine reasonable royalties for the alleged infringement by Intel. This included an assessment of the economic contribution of the patented technologies to Intel’s allegedly infringing products and analysis of the economic benefits from use of the patented technologies by Intel. As part of its work, Intensity evaluated all fifteen of the Georgia-Pacific factors.
Dr. Ryan Sullivan submitted a report and provided expert testimony at deposition and trial. After a six-day trial, the jury returned a verdict in favor of VLSI with a damages award that is consistent with Dr. Sullivan’s testimony. The jury awarded $1.5 billion for infringement of U.S. Patent No. 7,523,373 and $675 million for infringement of U.S. Patent No. 7,725,759. Total damages for infringement of the two patents is $2.175 billion, making it one of the largest jury verdicts for patent infringement in U.S. history.
Los Angeles Times coverage of the verdict can be found here. Law360 and Law.com coverage (subscriptions required) can be found here and here. In addition, Bloomberg Law coverage can be found here and here.
*Work performed by individuals while employed by Intensity, LLC. Intensity was acquired by Secretariat in February 2023.
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
Under Dr. Guyer’s leadership, the new Engineering & Scientific Consulting practice will provide the critical research, analysis, and investigations expertise necessary to solve the challenging science, engineering, and regulatory questions behind why products fail and the implications for stakeholders.
The US Music Industries: Jobs & Benefits — 2024 Report
Robert Stoner and Jéssica Dutra have recently published The U.S. Music Industries: Jobs & Benefits—2024 Report for the Recording Industry Association of America where we measure the music industries’ economic impact nationwide, which overall contribute $212 billion to the GDP and account for 2.5 million jobs.